SCHEMBL7686449

SCHEMBL7686449

COC(=O)CC(C[N+](=O)[O-])c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.41
CYP1A2 P05177 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
CYP2C9 P11712 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTR2C P28335 1/20 0.37
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL121197 0.84 ALDH1A1 (0.40) ALDH1A1MEN1KMT2A
SCHEMBL7684336 0.83 ALDH1A1 (0.40) ALDH1A1MAPT
SCHEMBL7687237 0.83 CNR1 (0.43) ALDH1A1MAPTHPGDNPSR1
SCHEMBL6492632 0.82 ALDH1A1 (0.40) ALDH1A1MAPTNPSR1HTTL3MBTL1
SCHEMBL6487215 0.82 ALDH1A1 (0.42) ALDH1A1
SCHEMBL6477248 0.82 CYP2C9 (0.45) CYP2C19ALDH1A1MAPTKDM4ENPSR1
SCHEMBL6489372 0.82 ALDH1A1 (0.40) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL5280121 0.81 CYP2C19 (0.51) CYP2C19CYP1A2ALDH1A1MAPTHPGD
SCHEMBL14582256 0.81 MTNR1A (0.45) CYP2C19CYP1A2ALDH1A1MAPTHPGD
SCHEMBL5280903 0.81 CYP2C19 (0.51) CYP2C19CYP1A2ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492392-B1 INHIBITING TUMOR CELL PROLIFERATION KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-12-10 US disclosed
WO-2001085716-A1 2-PIPERIDONE COMPOUNDS FOR THE TREATMENT OF CANCER KYOWA HAKKO KOGYO CO., LTD (JP) 2001-11-15 WO disclosed